 | Up a level |
Georgiopoulos, Georgios; Kraler, Simon; Mueller-Hennessen, Matthias; Delialis, Dimitrios; Mavraganis, Georgios; Sopova, Kateryna; Wenzl, Florian A; Räber, Lorenz; Biener, Moritz; Stähli, Barbara E; Maneta, Eleni; Spray, Luke; Iglesias, Juan F; Coelho-Lima, Jose; Tual-Chalot, Simon; Muller, Olivier; Mach, François; Frey, Norbert; Duerschmied, Daniel; Langer, Harald F; ... (2023). Modification of the GRACE Risk Score for Risk Prediction in Patients With Acute Coronary Syndromes. JAMA cardiology, 8(10), pp. 946-956. American Medical Association 10.1001/jamacardio.2023.2741
Barco, Stefano; Virdone, Saverio; Götschi, Andrea; Ageno, Walter; Arcelus, Juan I; Bingisser, Roland; Colucci, Giuseppe; Cools, Frank; Duerschmied, Daniel; Gibbs, Harry; Fumagalli, Riccardo M; Gerber, Bernhard; Haas, Sylvia; Himmelreich, Jelle C L; Hobbs, Richard; Hobohm, Lukas; Jacobson, Barry; Kayani, Gloria; Lopes, Renato D; MacCallum, Peter; ... (2023). Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials. Thrombosis research, 230, pp. 27-32. Elsevier 10.1016/j.thromres.2023.08.009
Voci, Davide; Götschi, Andrea; Held, Ulrike; Bingisser, Roland; Colucci, Giuseppe; Duerschmied, Daniel; Fumagalli, Riccardo M; Gerber, Bernhard; Hasse, Barbara; Keller, Dagmar I; Konstantinides, Stavros V; Mach, François; Rampini, Silvana K; Righini, Marc; Robert-Ebadi, Helia; Rosemann, Thomas; Roth-Zetzsche, Stéphanie; Sebastian, Tim; Simon, Noemi R; Spirk, David; ... (2023). Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial. Thrombosis research, 221, pp. 157-163. Elsevier 10.1016/j.thromres.2022.10.021
Hoch, Johannes; Burkhard, Niklas; Zhang, Shanshan; Rieder, Marina; Marchini, Timoteo; Geest, Vincent; Krauel, Krystin; Zahn, Timm; Schommer, Nicolas; Hamad, Muataz Ali; Bauer, Carolina; Gauchel, Nadine; Stallmann, Daniela; Normann, Claus; Wolf, Dennis; Scharf, Rüdiger Eberhard; Duerschmied, Daniel; Schanze, Nancy (2023). Serotonin transporter-deficient mice display enhanced adipose tissue inflammation after chronic high-fat diet feeding. Frontiers in immunology, 14, p. 1184010. Frontiers Research Foundation 10.3389/fimmu.2023.1184010
Akbil, Bengisu; Meyer, Tim; Stubbemann, Paula; Thibeault, Charlotte; Staudacher, Olga; Niemeyer, Daniela; Jansen, Jenny; Mühlemann, Barbara; Doehn, Jan; Tabeling, Christoph; Nusshag, Christian; Hirzel, Cédric; Sanchez, David Sökler; Nieters, Alexandra; Lother, Achim; Duerschmied, Daniel; Schallner, Nils; Lieberum, Jan Nikolaus; August, Dietrich; Rieg, Siegbert; ... (2022). Early and Rapid Identification of COVID-19 Patients with Neutralizing Type I Interferon Auto-antibodies. Journal of clinical immunology, 42(6), pp. 1111-1129. Springer 10.1007/s10875-022-01252-2
Barco, Stefano; Voci, Davide; Held, Ulrike; Sebastian, Tim; Bingisser, Roland; Colucci, Giuseppe; Duerschmied, Daniel; Frenk, André; Gerber, Bernhard; Götschi, Andrea; Konstantinides, Stavros V; Mach, François; Robert-Ebadi, Helia; Rosemann, Thomas; Simon, Noemi R; Spechbach, Hervé; Spirk, David; Stortecky, Stefan; Vaisnora, Lukas; Righini, Marc; ... (2022). Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet. Haematology, 9(8), e585-e593. Elsevier 10.1016/S2352-3026(22)00175-2
Steinfurt, Johannes; Bezzina, Connie R; Biermann, Jürgen; Staudacher, Dawid; Marschall, Christoph; Trolese, Luca; Faber, Thomas S; Duerschmied, Daniel; Zehender, Manfred; Bode, Christoph; Wilde, Arthur A M; Odening, Katja E; Lodder, Elisabeth M (2021). Two siblings with early repolarization syndrome: clinical and genetic characterization by whole-exome sequencing. EP Europace, 23(5), pp. 775-780. Oxford University Press 10.1093/europace/euaa357
